Proteomics and the search for biomarkers of female reproductive diseases

Reproduction

Volumn 140, Issue 4, 2010, Pages 505-509

  Meehan, Katie L ^a   Rainczuk, Adam ^a   Salamonsen, Lois A ^a   Stephens, Andrew N ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CELL PROTEIN; CYTOKINE; GLYCOPROTEIN; GROWTH FACTOR; HAPTOGLOBIN; PHOSPHOPROTEIN; TRANSFERRIN;

BODY FLUID; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURVIVAL; CELL CULTURE; COMBINATORIAL LIBRARY; DIAGNOSTIC VALUE; DIFFERENTIAL IN GEL ELECTROPHORESIS; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CELL; EPITHELIAL OVARIAN CANCER; FEMALE INFERTILITY; FRACTIONATION; GEL ELECTROPHORESIS; GEL PERMEATION CHROMATOGRAPHY; GENE EXPRESSION PROFILING; GENITAL SYSTEM; GYNECOLOGIC CANCER; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOHISTOCHEMISTRY; ISOELECTRIC FOCUSING; ISOTOPE DILUTION ASSAY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVIEW; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR MODEL; UTERINE CERVIX CANCER;

BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENDOMETRIOSIS; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MASS SPECTROMETRY; PROTEOMICS;

EID: 77957997860     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-10-0226     Document Type: Review

References (148)

1. Abbott KL, Lim JM, Wells L, Benigno BB, McDonald JF & Pierce M 2009 Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 10 470-481. (doi:10.1002/pmic. 200900537)
2. Aerni HR, Cornett DS & Caprioli RM 2006 Automated acoustic matrix deposition for MALDI sample preparation. Analytical Chemistry 78 827-834. (doi:10.1021/ac051534r)
3. Ametzazurra A, Matorras R, Garcia-Velasco JA, Prieto B, Simon L, Martinez A & Nagore D 2009 Endometrial fluid is a specific and non-invasive biological sample for protein biomarker identification in endometriosis. Human Reproduction 24 954-965. (doi:10.1093/humrep/den450)
4. Anderson NL 2010 The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clinical Chemistry 56 177-185. (doi:10.1373/clinchem.2009.126706)
5. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ & Ahn WS 2005 Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Gynecologic Oncology 99 26-35. (doi:10.1016/j.ygyno.2005.05.041)
6. Bengtsson S, Krogh M, Szigyarto CA, Uhlen M, Schedvins K, Silfversward C, Linder S, Auer G, Alaiya A & James P 2007 Largescale proteomics analysis of human ovarian cancer for biomarkers. Journal of Proteome Research 6 1440-1450. (doi:10.1021/pr060593y)
7. Blair AR & Casas CM 2009 Gynecologic cancers. Primary Care 36 115-130.
8. Boomsma CM, Kavelaars A, Eijkemans MJ, Amarouchi K, Teklenburg G, Gutknecht D, Fauser BJ, Heijnen CJ & Macklon NS 2009 Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity. Reproductive Biomedicine Online 18 85-94. (doi:10.1016/S1472-6483(10)60429-4)
9. Borgono CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M & Diamandis EP 2006 Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clinical Cancer Research 12 1487-1493. (doi:10.1158/1078-0432.CCR-05-2106)
10. Boschetti E & Righetti PG 2009 The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics 9 1492-1510. (doi:10.1002/pmic.200800389)
11. Braun DP, Gebel H, Rana N & Dmowski WP 1998 Cytolysis of eutopic and ectopic endometrial cells by peripheral blood monocytes and peritoneal macrophages in women with endometriosis. Fertility and Sterility 69 1103-1108. (doi:10.1016/S0015-0282(98)00062-4)
12. Bronstrup M 2004 Absolute quantification strategies in proteomics based on mass spectrometry. Expert Review of Proteomics 1 503-512. (doi:10. 1586/14789450.1.4.503)
13. Broomall EM, Reynolds SM & Jacobson RM 2010 Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Postgraduate Medicine 122 121-129. (doi:10.3810/pgm.2010.03.2129)
14. Brosens JJ, Hodgetts A, Feroze-Zaidi F, Sherwin JR, Fusi L, Salker MS, Higham J, Rose GL, Kajihara T, Young SL et al. 2009 Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis. Molecular Human Reproduction 16 273-285. (doi:10.1093/molehr/gap108)
15. Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, Nezhat CR, Lessey BA & Giudice LC 2007 Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinology 148 3814-3826. (doi:10. 1210/en.2006-1692)
16. Burnum KE, Tranguch S, Mi D, Daikoku T, Dey SK & Caprioli RM 2008 Imaging mass spectrometry reveals unique protein profiles during embryo implantation. Endocrinology 149 3274-3278. (doi:10.1210/en.2008-0309)
17. Cadron I, Van Gorp T, Timmerman D, Amant F, Waelkens E & Vergote I 2009 Application of proteomics in ovarian cancer: which sample should be used? Gynecologic Oncology 115 497-503. (doi:10.1016/j.ygyno.2009.09.005)
18. Casado-Vela J, Rodriguez-Suarez E, Iloro I, Ametzazurra A, Alkorta N, Garcia-Velasco JA, Matorras R, Prieto B, Gonzalez S, Nagore D et al. 2009 Comprehensive proteomic analysis of human endometrial fluid aspirate. Journal of Proteome Research 8 4622-4632. (doi:10.1021/pr9004426)
19. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS & Osann K 2006 Patterns and progress in ovarian cancer over 14 years. Obstetrics and Gynecology 108 521-528. (doi:10.1097/01. AOG.0000231680.58221.a7)
20. Chand AL, Murray AS, Jones RL, Hannan NJ, Salamonsen LA & Rombauts L 2007 Laser capture microdissection and cDNA array analysis of endometrium identify CCL16 and CCL21 as epithelial-derived inflammatory mediators associated with endometriosis. Reproductive Biology and Endocrinology 5 18. (doi:10.1186/1477-7827-5-18)
21. Chen J, Hannan N, Mak Y, Nicholls P, Zhang J, Rainczuk A, Stanton P, Robertson D, Salamonsen L & Stephens AN 2009 Proteomic characterization of mid-proliferative and mid-secretory human endometrium. Journal of Proteome Research 8 2032-2044. (doi:10.1021/pr801024g)
22. Choi KJ, Piao YJ, Lim MJ, Kim JH, Ha J, Choe W & Kim SS 2007 Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death. Cancer Research 67 3654-3662. (doi:10.1158/0008- 5472.CAN-06-1759)
23. Cicchillitti L, Di Michele M, Urbani A, Ferlini C, Donat MB, Scambia G & Rotilio D 2009 Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. Journal of Proteome Research 8 1902-1912. (doi:10.1021/pr800856b)
24. Cornett DS, Reyzer ML, Chaurand P & Caprioli RM 2007 MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nature Methods 4 828-833. (doi:10.1038/nmeth1094)
25. De Bock M, de Seny D, Meuwis M, Chapelle J, Louis E, Malaise M, Merville M & Fillet M 2010 Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. Journal of Biomedicine & Biotechnology 2010 1-15. (doi:10.1155/2010/906082)
26. DeSouza L, Diehl G, Rodrigues MJ, Guo J, Romaschin AD, Colgan TJ & Siu KW 2005a Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. Journal of Proteome Research 4 377-386. (doi:10.1021/pr049821j)
27. DeSouza L, Diehl G, Yang EC, Guo J, Rodrigues MJ, Romaschin AD, Colgan TJ & Siu KW 2005b Proteomic analysis of the proliferative and secretory phases of the human endometrium: protein identification and differential protein expression. Proteomics 5 270-281. (doi:10.1002/pmic.200400920)
28. DeSouza LV, Grigull J, Ghanny S, Dube V, Romaschin AD, Colgan TJ & Siu KW 2007 Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry. Molecular and Cellular Proteomics 6 1170-1182. (doi:10.1074/mcp.M600378-MCP200)
29. DeSouza LV, Taylor AM, Li W, Minkoff MS, Romaschin AD, Colgan TJ & Siu KW 2008 Multiple reaction monitoring of mTRAQ-labeled peptides enables absolute quantification of endogenous levels of a potential cancer marker in cancerous and normal endometrial tissues. Journal of Proteome Research 7 3525-3534. (doi:10.1021/pr800312m)
30. Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB & Rotilio D 2009a A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochimica et Biophysica Acta 1794 225-236. (doi:10.1016/j.bbapap. 2008.09.017)
31. Di Michele M, Marcone S, Cicchillitti L, Della Corte A, Ferlini C, Scambia G, Donati MB & Rotilio D 2009b Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: towards the identification of putative biomarkers. Journal of Proteomics 73 879-898. (doi:10.1016/j.jprot.2009.11.012)
32. Dominguez F, Garrido-Gomez T, Lopez JA, Camafeita E, Quinonero A, Pellicer A & Simon C 2009 Proteomic analysis of the human receptive versus non-receptive endometrium using differential in-gel electrophoresis and MALDI-MS unveils stathmin 1 and annexin A2 as differentially regulated. Human Reproduction 24 2607-2617. (doi:10. 1093/humrep/dep230)
33. Drapkin R, von Horsten HH, Lin Y, Mok SC, Crum CP, Welch WR & Hecht JL 2005 Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Research 65 2162-2169. (doi:10.1158/0008-5472.CAN-04-3924)
34. Drickamer K & Taylor ME 2002 Glycan arrays for functional glycomics. Genome Biology 3 1034.1-1034.4. (doi:10.1186/gb-2002-3-12-reviews1034)
35. Dunbar SA & Jacobson JW 2000 Application of the luminex LabMAP in rapid screening for mutations in the cystic fibrosis transmembrane conductance regulator gene: a pilot study. Clinical Chemistry 46 1498-1500.
36. Dyatlovitskaya EV, Andreasyan GO, Malykh Ya N, Rylova SN & Somova OG 1997 Ganglioside shedding and changes in ceramide biosynthesis in human ovarian tumors. Biochemistry 62 557-561.
37. Engelsen IB, Akslen LA & Salvesen HB 2009 Biologic markers in endometrial cancer treatment. Acta Pathologica, Microbiologica et Immunologica Scandinavica 117 693-707. (doi:10.1111/j.1600-0463.2009.02467.x)
38. Engwegen JY, Gast MC, Schellens JH & Beijnen JH 2006 Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry. Trends in Pharmacological Sciences 27 251-259. (doi:10.1016/j.tips.2006.03.003)
39. Ernoult E, Bourreau A, Gamelin E & Guette C 2010 A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation. Journal of Biomedicine & Biotechnology 2010 1-8. (doi:10.1155/2010/927917)
40. Espina V, Edmiston KH, Heiby M, Pierobon M, Sciro M, Merritt B, Banks S, Deng J, VanMeter AJ, Geho DH et al. 2008 A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Molecular and Cellular Proteomics 7 1998-2018. (doi:10.1074/mcp.M700596-MCP200)
41. Faca V, Coram M, Phanstiel D, Glukhova V, Zhang Q, Fitzgibbon M, McIntosh M & Hanash S 2006 Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. Journal of Proteome Research 5 2009-2018. (doi:10.1021/pr060102+)
42. Faca VM, Ventura AP, Fitzgibbon MP, Pereira-Faca SR, Pitteri SJ, Green AE, Ireton RC, Zhang Q, Wang H, O'Briant KC et al. 2008 Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PLoS ONE 3 e2425. (doi:10.1371/journal.pone.0002425)
43. Farias-Eisner G, Su F, Robbins T, Kotlerman J, Reddy S & Farias-Eisner R 2010 Validation of serum biomarkers for detection of early- and late-stage endometrial cancer. American Journal of Obstetrics and Gynecology 202 73.e1-73.e5. (doi:10.1016/j.ajog.2009.07.049)
44. Ferrero S, Gillott DJ, Remorgida V, Anserini P, Leung KY, Ragni N & Grudzinskas JG 2007 Proteomic analysis of peritoneal fluid in women with endometriosis. Journal of Proteome Research 6 3402-3411. (doi:10. 1021/pr060680q)
45. Ferrero S, Gillott DJ, Remorgida V, Ragni N, Venturini PL & Grudzinskas JG 2008 Proteomics technologies in endometriosis. Expert Review of Proteomics 5 705-714. (doi:10.1586/14789450.5.5.705)
46. Ferrero S, Gillott DJ, Remorgida V, Anserini P, Ragni N & Grudzinskas JG 2009 Proteomic analysis of peritoneal fluid in fertile and infertile women with endometriosis. Journal of Reproductive Medicine 54 32-40.
47. Fiorelli JL, Herzog TJ & Wright JD 2008 Current treatment strategies for endometrial cancer. Expert Review of Anticancer Therapy 8 1149-1157. (doi:10.1586/14737140.8.7.1149)
48. Fowler PA, Tattum J, Bhattacharya S, Klonisch T, Hombach-Klonisch S, Gazvani R, Lea RG, Miller I, Simpson WG & Cash P 2007 An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: a heterogeneous tissue with a complex disease. Proteomics 7 130-142. (doi:10.1002/pmic.200600469)
49. Fu Q, Zhu J & Van Eyk JE 2010 Comparison of multiplex immunoassay platforms. Clinical Chemistry 56 314-318. (doi:10.1373/clinchem.2009. 135087)
50. Giudice LC 2004 Microarray expression profiling reveals candidate genes for human uterine receptivity. American Journal of Pharmacogenomics 4 299-312. (doi:10.2165/00129785-200404050-00003)
51. Giuntoli RL II, Rodriguez GC, Whitaker RS, Dodge R & Voynow JA 1998 Mucin gene expression in ovarian cancers. Cancer Research 58 5546-5550.
52. Gonzalez-Santiago L, Alfonso P, Suarez Y, Nunez A, Garcia-Fernandez LF, Alvarez E, Munoz A & Casal JI 2007 Proteomic analysis of the resistance to aplidin in human cancer cells. Journal of Proteome Research 6 1286-1294. (doi:10.1021/pr060430+)
53. Griffiths WJ & Wang Y 2009 Mass spectrometry: from proteomics to metabolomics and lipidomics. Chemical Society Reviews 38 1882-1896. (doi:10.1039/b618553n)
54. von Gruenigen VE, Gil KM, Frasure HE, Jenison EL & Hopkins MP 2005 The impact of obesity and age on quality of life in gynecologic surgery. American Journal of Obstetrics and Gynecology 193 1369-1375. (doi:10.1016/j.ajog.2005.03.038)
55. Gu Y, Wu SL, Meyer JL, Hancock WS, Burg LJ, Linder J, Hanlon DW & Karger BL 2007 Proteomic analysis of high-grade dysplastic cervical cells obtained from ThinPrep slides using laser capture microdissection and mass spectrometry. Journal of Proteome Research 6 4256-4268. (doi:10. 1021/pr070319j)
56. Gunawardana CG, Kuk C, Smith CR, Batruch I, Soosaipillai A & Diamandis EP 2009 Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. Journal of Proteome Research 8 4705-4713. (doi:10.1021/pr900411g)
57. Guo J, Yang EC, Desouza L, Diehl G, Rodrigues MJ, Romaschin AD, Colgan TJ & Siu KW 2005 A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma. Proteomics 5 1953-1966. (doi:10.1002/pmic. 200401059)
58. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH & Aebersold R 1999 Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnology 17 994-999. (doi:10.1038/13690)
59. Hadfield R, Mardon H, Barlow D & Kennedy S 1996 Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Human Reproduction 11 878-880.
60. Hanash SM, Pitteri SJ & Faca VM 2008 Mining the plasma proteome for cancer biomarkers. Nature 452 571-579. (doi:10.1038/nature06916)
61. Hannan NJ, Stephens AN, Hincks C, Rainczuk A, Rombauts LJF & Salamonsen LA 2009a The endometrial secretome: potential roles in endometrial receptivity. Biology of Reproduction 81 419.
62. Hannan NJ, Stoikos CJ, Stephens AN & Salamonsen LA 2009b Depletion of high-abundance serum proteins from human uterine lavages enhances detection of lower-abundance proteins. Journal of Proteome Research 8 1099-1103. (doi:10.1021/pr800811y)
63. Hardesty WM & Caprioli RM 2008 In situ molecular imaging of proteins in tissues using mass spectrometry. Analytical and Bioanalytical Chemistry 391 899-903. (doi:10.1007/s00216-008-1972-5)
64. Hellman K, Alaiya AA, Schedvins K, Steinberg W, Hellstrom AC & Auer G 2004 Protein expression patterns in primary carcinoma of the vagina. British Journal of Cancer 91 319-326. (doi:10.1038/sj.bjc.6601944)
65. Horcajadas JA, Pellicer A & Simon C 2007 Wide genomic analysis of human endometrial receptivity: new times, new opportunities. Human Reproduction Update 13 77-86. (doi:10.1093/humupd/dml046)
66. Hubner NC, Ren S & Mann M 2008 Peptide separation with immobilized pI strips is an attractive alternative to in-gel protein digestion for proteome analysis. Proteomics 8 4862-4872. (doi:10. 1002/pmic.200800351)
67. Hutchens TW & Tai-Tung Y 1993 New desorption strategies for the mass spectrometric analysis of macromolecules. Rapid Communications in Mass Spectrometry 7 576-580. (doi:10.1002/rcm.1290070703)
68. Huttenhain R, Malmstrom J, Pitcotti P & Aebersold R 2009 Perspectives of targeted mass spectrometry for protein biomarker verification. Current Opinion in Chemical Biology 13 518-525. (doi:10.1016/j.cbpa.2009. 09.014)
69. Imre T, Kremmer T, Heberger K, Molnar-Szollosi E, Ludanyi K, Pocsfalvi G, Malorni A, Drahos L & Vekey K 2008 Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals. Journal of Proteomics 71 186-197. (doi:10.1016/j.jprot.2008.04.005)
70. Issaq HJ, Veenstra TD, Conrads TP & Felschow D 2002 The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochemical and Biophysical Research Communications 292 587-592. (doi:10.1006/bbrc.2002.6678)
71. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T & Thun MJ 2008 Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 58 71-96. (doi:10. 3322/CA.2007.0010)
72. Kang S, Shim HS, Lee JS, Kim DS, Kim HY, Hong SH, Kim PS, Youn JH & Cho NH 2010 Molecular proteomics imaging of tumor interfaces by mass spectrometry. Journal of Proteome Research 9 1157-1164. (doi:10. 1021/pr900666q)
73. Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, Taylor RN, Osteen K, Lessey BA & Giudice LC 2003 Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144 2870-2881. (doi:10.1210/en.2003-0043)
74. Kim JH, Skates SJ, Uede T, Wong KK, Schorge JO, Feltmate CM, Berkowitz RS, Cramer DW & Mok SC 2002 Osteopontin as a potential diagnostic biomarker for ovarian cancer. Journal of the American Medical Association 287 1671-1679. (doi:10.1001/jama.287.13.1671)
75. Kim A, Enomoto T, Serada S, Ueda Y, Takahashi T, Ripley B, Miyatake T, Fujita M, Lee CM, Morimoto K et al. 2009 Enhanced expression of Annexin A4 in clear cell carcinoma of the ovary and its association with chemoresistance to carboplatin. International Journal of Cancer 125 2316-2322. (doi:10.1002/ijc. 24587)
76. Kitteringham NR, Jenkins RE, Lane CS, Elliott VL & Park BK 2009 Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 877 1229-1239. (doi:10.1016/j.jchromb.2008.11.013)
77. Kozak KR, Su F, Whitelegge JP, Faull K, Reddy S & Farias-Eisner R 2005 Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 5 4589-4596. (doi:10.1002/pmic.200500093)
78. Kuk C, Kulasingam V, Gunawardana CG, Smith CR, Batruch I & Diamandis EP 2009 Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Molecular and Cellular Proteomics 8 661-669. (doi:10.1074/mcp. M800313-MCP200)
79. Kyama CM, Overbergh L, Debrock S, Valckx D, Vander Perre S, Meuleman C, Mihalyi A, Mwenda JM, Mathieu C & D'Hooghe TM 2006 Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis. Fertility and Sterility 85 1667-1675. (doi:10.1016/j.fertnstert.2005.11.060)
80. Lacey JV Jr & Chia VM 2009 Endometrial hyperplasia and the risk of progression to carcinoma. Maturitas 63 39-44. (doi:10.1016/j.maturitas. 2009.02.005)
81. Latterich M, Abramovitz M & Leyland-Jones B 2008 Proteomics: new technologies and clinical applications. European Journal of Cancer 44 2737-2741. (doi:10.1016/j.ejca.2008.09.007)
82. Lemaire R, Menguellet SA, Stauber J, Marchaudon V, Lucot JP, Collinet P, Farine MO, Vinatier D, Day R, Ducoroy P et al. 2007 Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex. Reg alpha fragment, is a new potential ovary cancer biomarker. Journal of Proteome Research 6 4127-4134. (doi:10.1021/pr0702722)
83. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, Roh MH, Kindelberger DW, Hirsch MS, Crum CP, Marto JA et al. 2010 Primary ex vivo cultures of human fallopian tube epithelium as amodel for serous ovarian carcinogenesis. Oncogene 29 1103-1113. (doi:10.1038/onc.2009.402)
84. Li B, An HJ, Kirmiz C, Lebrilla CB, Lam KS & Miyamoto S 2008a Glycoproteomic analyses of ovarian cancer cell lines and sera from ovarian cancer patients show distinct glycosylation changes in individual proteins. Journal of Proteome Research 7 3776-3788. (doi:10.1021/pr800297u)
85. Li Z, Huang C, Bai S, Pan X, Zhou R, Wei Y & Zhao X 2008b Prognostic evaluation of epidermal fatty acid-binding protein and calcyphosine, two proteins implicated in endometrial cancer using a proteomic approach. International Journal of Cancer 123 2377-2383. (doi:10.1002/ijc.23808)
86. Li Z, Zhao X, Bai S, Wang Z, Chen L, Wei Y & Huang C 2008c Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Molecular and Cellular Proteomics 7 1810-1823. (doi:10.1074/mcp.M700544-MCP200)
87. Lin YW, Lai HC, Lin CY, Chiou JY, Shui HA, Chang CC, Yu MH & Chu TY 2006 Plasma proteomic profiling for detecting and differentiating in situ and invasive carcinomas of the uterine cervix. International Journal of Gynecological Cancer 16 1216-1224. (doi:10.1111/j.1525-1438.2006. 00583.x)
88. Link AJ, Eng J, Schieltz DM, Carmack E, Mize GJ, Morris DR, Garvik BM & Yates JR III 1999 Direct analysis of protein complexes using mass spectrometry. Nature Biotechnology 17 676-682. (doi:10.1038/10890)
89. Liu H, Sadygov RG & Yates JR III 2004 A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Analytical Chemistry 76 4193-4201. (doi:10.1021/ac0498563)
90. Liu H, Lang J, Zhou Q, Shan D & Li Q 2007 Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Fertility and Sterility 87 988-990. (doi:10.1016/j.fertnstert.2006.08.095)
91. Luchini A, Geho DH, Bishop B, Tran D, Xia C, Dufour RL, Jones CD, Espina V, Patanarut A, Zhou W et al. 2008 Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation. Nano Letters 8 350-336. (doi:10.1021/nl072174l)
92. Luo LY, Soosaipillai A, Grass L & Diamandis EP 2006 Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Tumour Biology 27 227-234. (doi:10.1159/000094693)
93. McIntosh MW, Liu Y, Drescher C, Urban N & Diamandis EP 2007 Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma. Clinical Cancer Research 13 4422-4428. (doi:10.1158/1078-0432.CCR-06-2224)
94. Meehan KL & Sadar MD 2004 Quantitative profiling of LNCaP prostate cancer cells using isotope-coded affinity tags and mass spectrometry. Proteomics 4 1116-1134. (doi:10.1002/pmic.200300649)
95. Meriaux C, Franck J,Wisztorski M, Salzet M& Fournier I 2010 Liquid ionic matrixes for MALDI mass spectrometry imaging of lipids. Journal of Proteomics 73 1204-1218. (doi:10.1016/j.jprot.2010.02.010)
96. Miller I, Crawford J & Gianazza E 2006 Protein stains for proteomic applications: which, when, why? Proteomics 6 5385-5408. (doi:10. 1002/pmic.200600323)
97. Monge M, Colas E, Doll A, Gil-Moreno A, Castellvi J, Diaz B, Gonzalez M, Lopez-Lopez R, Xercavins J, Carreras R et al. 2009a Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress. Carcinogenesis 30 1288-1297. (doi:10.1093/carcin/bgp119)
98. Monge M, Doll A, Colas E, Gil-Moreno A, Castellvi J, Garcia A, Colome N, Perez-Benavente A, Pedrola N, Lopez-Lopez R et al. 2009b Subtractive proteomic approach to the endometrial carcinoma invasion front. Journal of Proteome Research 8 4676-4684. (doi:10.1021/pr900390t)
99. Moseley MA 2001 Current trends in differential expression proteomics: isotopically coded tags. Trends in Biotechnology 19 S10-S16. (doi:10. 1016/S0167-7799(01)01793-0)
100. Nagele E, Vollmer M, Horth P & Vad C 2004 2D-LC/MS techniques for the identification of proteins in highly complex mixtures. Expert Review of Proteomics 1 37-46. (doi:10.1586/14789450.1.1.37)
101. Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A & Mann M 2002 Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Molecular and Cellular Proteomics 1 376-386. (doi:10.1074/mcp. M200025-MCP200)
102. Ostrowski J & Wyrwicz LS 2009 Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Expert Review of Molecular Diagnostics 9 623-630. (doi:10.1586/erm.09.41)
103. Pan J, Chen HQ, Sun YH, Zhang JH & Luo XY 2008 Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology. Lung 186 255-261. (doi:10. 1007/s00408-008-9093-7)
104. Pan S, Cheng L, White JT, Lu W, Utleg AG, Yan X, Urban ND, Drescher CW, Hood L & Lin B 2009 Quantitative proteomics analysis integrated with microarray data reveals that extracellular matrix proteins, catenins, and P53 binding protein 1 are important for chemotherapy response in ovarian cancers. OMICS 13 345-354. (doi:10.1089/omi.2009.0008)
105. Papanicolaou GN 1942 A new procedure for staining vaginal smears. Science 95 438-439. (doi:10.1126/science.95.2469.438)
106. Parmar T, Gadkar-Sable S, Savardekar L, Katkam R, Dharma S, Meherji P, Puri CP & Sachdeva G 2009 Protein profiling of human endometrial tissues in the midsecretory and proliferative phases of the menstrual cycle. Fertility and Sterility 92 1091-1103. (doi:10.1016/j.fertnstert. 2008.07.1734)
107. Petri AL, Simonsen AH, Yip TT, Hogdall E, Fung ET, Lundvall L & Hogdall C 2009 Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology. Acta Obstetricia et Gynecologica Scandinavica 88 18-26. (doi:10.1080/00016340802443830)
108. Pitteri SJ, JeBailey L, Faca VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q et al. 2009 Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS ONE 4 e7916. (doi:10.1371/journal.pone.0007916)
109. Poetz O, Hoeppe S, Templin MF, Stoll D & Joos TO 2009 Proteome wide screening using peptide affinity capture. Proteomics 9 1518-1523. (doi:10.1002/pmic.200800842)
110. Ponnampalam AP, Weston GC, Susil B & Rogers PA 2006 Molecular profiling of human endometrium during the menstrual cycle. Australian and New Zealand Journal of Obstetrics and Gynaecology 46 154-158. (doi:10.1111/j.1479- 828X.2006.00547.x)
111. Rai AJ & Vitzthum F 2006 Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics. Expert Review of Proteomics 3 409-426. (doi:10. 1586/14789450.3.4.409)
112. Rainczuk A, Meehan K, Steer DL, Stanton PG, Robertson DM & Stephens AN 2010 An optimized procedure for the capture, fractionation and proteomic analysis of proteins using hydrogel nanoparticles. Proteomics 10 332-336. (doi:10.1002/pmic.200900187)
113. Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P & Fairclough L 2010 Quantitative validation and comparison of multiplex cytokine kits. Journal of Biomolecular Screening 15 562-568. (doi:10.1177/1087057110362099)
114. Risum S, Hogdall E, Engelholm SA, Fung E, Lomas L, Yip C, Petri AL, Nedergaard L, Lundvall L & Hogdall C 2009 A proteomics panel for predicting optimal primary cytoreduction in stage III/IV ovarian cancer. International Journal of Gynecological Cancer 19 1535-1538.
115. Robertson DM, Pruysers E & Jobling T 2007 Inhibin as a diagnostic marker for ovarian cancer. Cancer Letters 249 14-17. (doi:10.1016/j.canlet. 2006.12.017)
116. Rylova SN, Somova OG & Dyatlovitskaya EV 1998 Comparative investigation of sphingoid bases and fatty acids in ceramides and sphingomyelins from human ovarian malignant tumors and normal ovary. Biochemistry 63 1057-1060.
117. Salamonsen LA, Nie G, Hannan NJ & Dimitriadis E 2009 Society for Reproductive Biology Founders' Lecture 2009. Preparing fertile soil: the importance of endometrial receptivity. Reproduction, Fertility, and Development 21 923-934. (doi:10.1071/RD09145)
118. Schmidt A, Kellermann J & Lottspeich F 2005 A novel strategy for quantitative proteomics using isotope-coded protein labels. Proteomics 5 4-15. (doi:10.1002/pmic.200400873)
119. Schmidt A, Claassen M & Aebersold R 2009 Directed mass spectrometry: towards hypothesis-driven proteomics. Current Opinion in Chemical Biology 13 510-517. (doi:10.1016/j.cbpa.2009.08.016)
120. Scotchie JG, Fritz MA, Mocanu M, Lessey BA & Young SL 2009 Proteomic analysis of the luteal endometrial secretome. Reproductive Sciences 16 883-893. (doi:10.1177/1933719109337165)
121. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J & Barnhart KT 2008 Panel of markers can accurately predict endometriosis in a subset of patients. Fertility and Sterility 89 1073-1081. (doi:10.1016/ j.fertnstert.2007.05.014)
122. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J & Barnhart KT 2009 Proteomic analysis of serum yields six candidate proteins that are differentially regulated in a subset of women with endometriosis. Fertility and Sterility 93 2137-2144. (doi:10.1016/j. fertnstert.2008.12.121)
123. Seppala M, Koistinen H, Mandelin E & Koistinen R 1998 Importance of uterus and sperm glycodelins in the regulation of reproduction. Duodecim 114 761-767.
124. Shan SJ, Scorilas A, Katsaros D, Rigault de la Longrais I, Massobrio M & Diamandis EP 2006 Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols. Clinical Chemistry 52 1879-1886. (doi:10.1373/clinchem.2006.071456)
125. Shih Ie M, Salani R, Fiegl M, Wang TL, Soosaipillai A, Marth C, Muller- Holzner E, Gastl G, Zhang Z & Diamandis EP 2007 Ovarian cancer specific kallikrein profile in effusions. Gynecologic Oncology 105 501-507. (doi:10.1016/j.ygyno.2007.01.018)
126. Stempfer R, Kubicek M, Lang IM, Christa N & Gerner C 2008 Quantitative assessment of human serum high-abundance protein depletion. Electrophoresis 29 4316-4323. (doi:10.1002/elps.200800211)
127. Stephens A, Hannan N, Rainczuk A, Meehan K, Chen J, Nicholls P, Rombauts L, Stanton P, Robertson D & Salamonsen L 2010 Posttranslational modifications and protein-specific isoforms in endometriosis revealed by 2D DIGE. Journal of Proteome Research 9 2438-2449. (doi:10.1021/pr901131p)
128. Takano M, Kikuchi Y, Asakawa T, Goto T, Kita T, Kudoh K, Kigawa J, Sakuragi N, Sakamoto M, Sugiyama T et al. 2010 Identification of potential serum markers for endometrial cancer using protein expression profiling. Journal of Cancer Research and Clinical Oncology 136 475-481. (doi:10.1007/s00432-009-0680- 7)
129. Taouji S, Dahan S, Bosse R & Chevet E 2009 Current screens based on the alpha screen technology for deciphering cell signalling pathways. Current Genomics 10 93-101. (doi:10.2174/138920209787847041)
130. Timms JF & Cramer R 2008 Difference gel electrophoresis. Proteomics 8 4886-4897. (doi:10.1002/pmic.200800298)
131. Tokushige N, Russell P, Black K, Barrera H, Dubinovsky S, Markham R & Fraser IS 2010 Nerve fibers in ovarian endometriomas. Fertility and Sterility. (doi:10.1016/j.fertnstert.2009.12.074)
132. Unlu M, Morgan ME & Minden JS 1997 Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 2071-2077. (doi:10.1002/elps.1150181133)
133. Vignali DA 2000 Multiplexed particle-based flow cytometric assays. Journal of Immunological Methods 243 243-255. (doi:10.1016/S0022-1759(00)00238- 6)
134. Wang J, Zhang X, Ge X, Guo H, Xiong G & Zhu Y 2008 Proteomic studies of early-stage and advanced ovarian cancer patients. Gynecologic Oncology 111 111-119. (doi:10.1016/j.ygyno.2008.06.031)
135. Wang J, Zhang HR, Shi HJ, Ma D, Zhao HX, Lin B & Li RS 2009 Proteomic analysis of seminal plasma from asthenozoospermia patients reveals proteins that affect oxidative stress responses and semen quality. Asian Journal of Andrology 11 484-491. (doi:10.1038/aja.2009.26)
136. Weintraub J & Morabia A 2000 Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer. Diagnostic Cytopathology 22 52-59. (doi:10.1002/ (SICI)1097-0339(200001)22:1〈52::AID-DC14〉3.0.CO;2-#)
137. Wilson KE, Marouga R, Prime JE, Pashby DP, Orange PR, Crosier S, Keith AB, Lathe R, Mullins J, Estibeiro P et al. 2005 Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling. Proteomics 5 3851-3858. (doi:10.1002/pmic.200401255)
138. Wingren C & Borrebaeck CA 2009 Antibody-based microarrays. Methods in Molecular Biology 509 57-84.
139. Wingren C, James P & Borrebaeck CA 2009 Strategy for surveying the proteome using affinity proteomics and mass spectrometry. Proteomics 9 1511-1517. (doi:10.1002/pmic.200800802)
140. Yocum AK & Chinnaiyan AM 2009 Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry. Briefings in Functional Genomics & Proteomics 8 145-157. (doi:10.1093/bfgp/eln056)
141. Zaia J 2008 Mass spectrometry and the emerging field of glycomics. Chemistry & Biology 15 881-892. (doi:10.1016/j.chembiol.2008.07.016)
142. Zegels G, Van Raemdonck GA, Coen EP, Tjalma WA & Van Ostade XW 2009 Comprehensive proteomic analysis of human cervical - vaginal fluid using colposcopy samples. Proteome Science 7 17. (doi:10.1186/1477-5956-7-17)
143. Zhao Q, Duan W, Wu YM, Qian XH & Deng XH 2008 Analysis of serum biomarkers of ovarian epithelial cancers based on 2-DE DIGE and MALDI TOF/TOF. Zhonghua Zhong Liu Za Zhi 30 754-758.
144. Zhou H, Dai J, Sheng QH, Li RX, Shieh CH, Guttman A & Zeng R 2007 A fully automated 2-D LC-MS method utilizing online continuous pH and RP gradients for global proteome analysis. Electrophoresis 28 4311-4319. (doi:10.1002/elps.200700463)
145. Zhou W, Ross MM, Tessitore A, Ornstein D, Vanmeter A, Liotta LA & Petricoin EF III 2009 An initial characterization of the serum phosphoproteome. Journal of Proteome Research 8 5523-5531. (doi:10.1021/pr900603n)
146. Zhu LR, Zhang WY, Yu L, Zheng YH, Hu J & Liao QP 2008 Proteiomic patterns for endometrial cancer using SELDI-TOF-MS. Journal of Zhejiang University. Science. B 9 286-290. (doi:10.1631/jzus.B0710589)
147. Zhu X, Lv J, Yu L, Wu J, Zou S & Jiang S 2009 Proteomic identification of differentially-expressed proteins in squamous cervical cancer. GynecologicOncology 112 248-256. (doi:10.1016/j.ygyno.2008.09.045)
148. Zybailov B, Coleman MK, Florens L & Washburn MP 2005 Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Analytical Chemistry 77 6218-6224. (doi:10.1021/ac050846r)